After obtaining her PhD from Friedrich-Alexander University (FAU) in Erlangen, Germany, where she studied potential therapies for B cell leukemia, Miriam joined the lab of Professor Meinrad Busslinger at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria. Here, she worked on a variety of transcription factors involved in plasma cell development, germinal center formation, and class-switch recombination. This work included a comprehensive 3,000-gene CRISPR-Cas9 screen to elucidate novel factors important for plasmablast development. In 2022, Miriam joined the lab of Professor Falk Nimmerjahn at FAU, where she is currently investigating the role of different macrophage subsets in metastasis development and growth.